MedInsight Research Institute

MedInsight Research Institute is a non-profit organization dedicated to the scientific evaluation and repurposing of existing, off-patent medications for new therapeutic indications. The institute focuses on identifying cost-effective treatments for chronic and life-threatening conditions, including oncology, autoimmune disorders, and infectious diseases. By leveraging clinical data and conducting independent research, MedInsight aims to bridge the gap between academic discovery and clinical application. Their notable work includes extensive research into low-dose naltrexone (LDN) for various conditions and the use of dipyridamole for ocular and viral applications. The organization operates globally, collaborating with clinicians and researchers to validate treatments that may lack traditional commercial incentives.